To the content
1 . 2016

Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices

Abstract

Key points

  • Patients with symptomatic inappropriate bradycardia from either sinus node dysfunction or atrioventricular (AV) block should be evaluated for a pacemaker.
  • Patients who are asymptomatic with AV block and have heart rates less than 40 beats per minute or asystolic pauses greater than 3 seconds in sinus rhythm or greater than 5 seconds in atrial fibrillation WHILE AWAKE should be evaluated for a pacemaker.
  • Patients who have symptomatic sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) or have survived a cardiac arrest caused by VT/VF not from a reversible cause should be evaluated for implantable cardioverterdefibrillator (ICD).
  • Patients who have chronic left ventricular (LV) systolic heart failure on guideline-directed medical therapy (GDMT) with an LV ejection fraction (EF) of 35% or less with New York Heart Association functional class II or III should be evaluated for ICD.
  • Patients who have chronic LV systolic heart failure on GDMT with sinus rhythm and left bundle branch block and EF of 35% or less with QRS duration of 150 ms or greater should be evaluated for cardiac resynchronization therapy.

Med Clin N Am. 2015; Vol. 99: 795–804;

http://dx.doi.org/10.1016/j.mcna.2015.02.008

Keywords: arrhythmia, cardiac rhythm devices, pacemaker, implantable cardioverter-defibrillator, cardiac resynchroniza tion therapy, systolic heart failure

Dear readers!

Full-text version of the article is available only in paper version.

CHIEF EDITOR
CHIEF EDITOR
Andrey G. Obrezan
MD, Professor, Head of the Hospital Therapy Department of the Saint Petersburg State University, Chief Physician of SOGAZ MEDICINE Clinical Group, St. Petersburg, Russian Federation

Journals of «GEOTAR-Media»